Synarel (nafarelin acetate) 200 mcg nasal solution, only Searle NDA 19-886/S-013 12/24/98 12/29/98 7/21/99 Synarel Indication:provides for revisions to the CLINICAL PHARMACOLOGY and ADVERSE REACTIONS sections of the labeling (endometriosis)

For the most up-to-date approval information, please locate this API using the drug index.